Research & Development

At Simris, our discovery engine is powered by the world’s largest cyanobacterial strain library – containing over 5,000 novel, natural compounds. These include promising candidates for a wide range of therapeutic, agricultural, and cosmetic applications.

Our Focus Areas:

Antibody-Drug Conjugates (ADCs)

Our most advanced research area. We are developing next-generation payloads to dramatically improve the safety and efficacy of cancer therapies.

CyAge – Ageing-Related Diseases


We’re investigating cyanobacterial compounds for their potential to treat age-related conditions, co-funded by Investitionsbank Berlin and the European Regional Development Fund (EFRE).

AgriBio & Natural Product Discovery


From antimicrobials to plant stimulants, our library contains valuable hits and leads for novel pesticides, fungicides, herbicides, pigments and more. If you are interested in partnering with us, contact our team.

© 2025 Simris Biologics · Novel natural biologics sustainably sourced from cyanobacteria and microalgae. All rights reserved.

Simris Biologics is a part of the Simris Group.